These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 13326290)

  • 21. [Resistance of Mycobacterium tuberculosis to isonicotinic acid hydrazide].
    NITTI V
    Arch Tisiol Mal Appar Respir; 1952 Sep; 7(9):735-43. PubMed ID: 13017972
    [No Abstract]   [Full Text] [Related]  

  • 22. [Irreversibility of inhibitory action of isonicotinic acid hydrazide on Mycobacterium tuberculosis].
    LINZ R
    C R Seances Soc Biol Fil; 1952 Sep; 146(17-18):1449-51. PubMed ID: 13020206
    [No Abstract]   [Full Text] [Related]  

  • 23. [Examination of resistance of Mycobacterium tuberculosis to isonicotinic acid hydrazide].
    GIUNIO N
    Tuberkuloza; 1953; 5(3):218-30. PubMed ID: 13157196
    [No Abstract]   [Full Text] [Related]  

  • 24. [In vitro sensitivity of Mycobacterium tuberculosis to isonicotinic acid hydrazide].
    LINZ R; LECOCQ E
    C R Seances Soc Biol Fil; 1952 Sep; 146(17-18):1444-7. PubMed ID: 13020204
    [No Abstract]   [Full Text] [Related]  

  • 25. [Catalase activity and isoniazid sensitivity of pathogenic mycobacteria].
    VIALLIER J; CAYRE RM
    Ann Inst Pasteur (Paris); 1956 Mar; 90(3):373-4. PubMed ID: 13327490
    [No Abstract]   [Full Text] [Related]  

  • 26. Laboratory studies of the isonicotinic acid hydrazides in tuberculosis.
    WAGNER BM; KUHNS DM; FUSILLO MH
    U S Armed Forces Med J; 1952 Nov; 3(11):1741-5. PubMed ID: 12995571
    [No Abstract]   [Full Text] [Related]  

  • 27. [Investigations on virulence of Mycobacterium tuberculosis resistant to isonicotinic acid hydrazide].
    ZEBROWSKI T; PIENIAZEK J; BOROWIECKA A; ZAREMBA J
    Gruzlica (1926); 1955 May; 23(5):297-304. PubMed ID: 13251604
    [No Abstract]   [Full Text] [Related]  

  • 28. [Action of isonicotinic acid hydrazide on strains of Mycobacterium tuberculosis].
    GHIONE M
    Boll Soc Ital Biol Sper; 1952 May; 28(5):994-6. PubMed ID: 13018589
    [No Abstract]   [Full Text] [Related]  

  • 29. [Phenomenon of extinction and resistance of Mycobacterium tuberculosis to isonicotinic acid hydrazide].
    ZEBROWSKI T; PIENIAZEK J; BOROWIECKA A
    Gruzlica (1926); 1954 Mar; 22(3):173-7. PubMed ID: 13183394
    [No Abstract]   [Full Text] [Related]  

  • 30. [In vitro and in vivo antituberculous action of isonicotinic acid hydrazide (isoniazide)].
    REGINSTER A
    Rev Med Liege; 1953 May; 8(10):329-36. PubMed ID: 13101143
    [No Abstract]   [Full Text] [Related]  

  • 31. [Tuberculosis bacilli of weak virulence isolated after isoniazid therapy].
    BERNARD E; KREIS B; LE JOUBIOUX E
    Rev Tuberc; 1955 Nov; 19(10-11):1113-44; discussion, 1185-7. PubMed ID: 13311186
    [No Abstract]   [Full Text] [Related]  

  • 32. Isoniazid resistance.
    MIDDLEBROOK G; DRESSLER SH
    Lancet; 1955 Mar; 268(6865):669-70. PubMed ID: 14354966
    [No Abstract]   [Full Text] [Related]  

  • 33. The inactivation of isoniazid by filtrates and extracts of mycobacteria.
    YOUMANS AS; YOUMANS GP
    Am Rev Tuberc; 1955 Aug; 72(2):196-203. PubMed ID: 13238779
    [No Abstract]   [Full Text] [Related]  

  • 34. [Variation in oxygen consumption in tubercle bacillus and lung tissue induced by isoniazid and several of its derivatives].
    CREMA A; GAFFURI P
    Boll Soc Ital Biol Sper; 1955; 31(9-10):1126-9. PubMed ID: 13329036
    [No Abstract]   [Full Text] [Related]  

  • 35. Differences between the effect of isonicotylhydrazide (neoteben, rimifon) in vitro and in guinea pigs.
    WILDE W
    Med Monatsschr; 1952 Nov; 6(11):706-7. PubMed ID: 13024743
    [No Abstract]   [Full Text] [Related]  

  • 36. Bacteriological control during isoniazid therapy.
    OGILVIE CM
    Lancet; 1953 Aug; 265(6783):451-2. PubMed ID: 13085812
    [No Abstract]   [Full Text] [Related]  

  • 37. The prevalence of streptomycin- and isoniazid-resistant strains of Mycobacterium tuberculosis in patients with newly discovered and untreated active pulmonary tuberculosis.
    CHAVES AD; ROBINS AB; ABELES H; PEIZER LR; DANGLER G; WIDELOCK D
    Am Rev Tuberc; 1955 Aug; 72(2):143-50. PubMed ID: 13238775
    [No Abstract]   [Full Text] [Related]  

  • 38. Mode of action of isoniazid.
    ALBERT A
    Nature; 1956 Mar; 177(4507):525-6. PubMed ID: 13321893
    [No Abstract]   [Full Text] [Related]  

  • 39. [Bacterial sensitivity in pulmonary tuberculosis under isonicotinic acid hydrazide therapy].
    BEEUWKES H; ESSEVELD H
    Ned Tijdschr Geneeskd; 1952 Aug; 96(34):2061-4. PubMed ID: 13013355
    [No Abstract]   [Full Text] [Related]  

  • 40. CHANGES in isoniazid resistance of tubercle bacilli after cessation of treatment; report by the Laboratory Subcommittee of the Tuberculosis Chemotherapy Trials Committee, Medical Research Council; M.R.C. isoniazid trial: Report No. 6.
    Thorax; 1954 Dec; 9(4):254-9. PubMed ID: 13226306
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.